Allergic Conjunctivitis (AC)- Market Insights, Epidemiology and Market Forecast- 2027

Posted on Jul 10, 2018 by Delveinsight

allergic conjunctivitis

(Visited 112 times, 1 visits today)

← Previous Story
Allergic Conjunctivitis (AC) – Common disorder with increasing prevalence

→

transthyretin amyloidosis

Next Story
Notizia

Related Posts

Pharma news fro GSK, InCarda, BridgeBio

GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; BridgeBio’s R&D deal

Oct 22, 2020• Pharma, Latest Pharma News, Health News

GSK eyes robust immune response from RSV vaccine Cold viruses mostly do not get much attention in terms of R&D. They usually make...

Read More →

Samsung/AZ Deal; Gyroscope’s GT005; Inflazome's Buyout; Abbott's MitraClip4; Grail Buyback

Samsung/AZ Deal; Gyroscope’s Dry AMD Gene Therapy; Inflazome’s Buyout; Abbott’s MitraClip4 EU Approval; Grail Buybacks

Sep 22, 2020• Pharma, Latest Pharma News, Health News

Samsung Biologics strikes a USD 330.8 Mn supply deal with AstraZeneca Samsung Biologics announced the conclusion of a long-term...

Read More →

Pharma News

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

Dec 12, 2019• Business Consultant, DelveInsight's Oncology based Reports, Notizia - Recent Pharma, Healthcare and Biotech Happenings, Pharma Consultant, The Business Cocktail

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than...

Read More →

pharma news

Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Dec 10, 2019• Business Consultant, DelveInsight's Drug Report, Notizia - Recent Pharma, Healthcare and Biotech Happenings, Oncology based Indications, Pharma Consultant, The Business Cocktail

Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion. Under the terms of the agreement, Merck will pay...

Read More →

Leave a Reply Cancel reply

↑

Close